Argus Research Remains a Buy on Solventum Corporation (SOLV)

Tip Ranks
2025.12.13 16:45
portai
I'm PortAI, I can summarize articles.

Argus Research's David Toung maintained a Buy rating on Solventum Corporation, with shares closing at $82.98. Toung, a 5-star analyst, has a 9.7% average return and a 64.60% success rate. Solventum also received a Buy from TR | OpenAI – 4o’s Rosa Clinessa, while Wells Fargo maintained a Hold rating.

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Solventum Corporation. The company’s shares closed yesterday at $82.98.

Claim 50% Off TipRanks Premium and Invest with Confidence

  • Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
  • Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential

According to TipRanks, Toung is a 5-star analyst with an average return of 9.7% and a 64.60% success rate. Toung covers the Healthcare sector, focusing on stocks such as Charles River Labs, Humana, and Johnson & Johnson.

In addition to Argus Research, Solventum Corporation also received a Buy from TR | OpenAI – 4o’s Rosa Clinessa in a report issued on December 7. However, yesterday, Wells Fargo maintained a Hold rating on Solventum Corporation (NYSE: SOLV).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.